Jill Merrill

712 total citations
22 papers, 561 citations indexed

About

Jill Merrill is a scholar working on Pharmacology, Small Animals and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Jill Merrill has authored 22 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Small Animals and 5 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Jill Merrill's work include Pharmacogenetics and Drug Metabolism (8 papers), Animal testing and alternatives (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Jill Merrill is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Animal testing and alternatives (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Jill Merrill collaborates with scholars based in United States, Canada and Italy. Jill Merrill's co-authors include Carole R. Mendelson, Sandra E. Graham-Lorence, Evan R. Simpson, Stephen Safe, Tammy Μ. Bray, C. Jo Corbin, E R Simpson, Claudia T. Evans, Iain B. Lambert and Stelvio M. Bandiera and has published in prestigious journals such as Journal of Biological Chemistry, Endocrine Reviews and Journal of Nutrition.

In The Last Decade

Jill Merrill

22 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Merrill United States 11 166 144 88 88 76 22 561
Hitoshi Funabashi Japan 12 53 0.3× 279 1.9× 84 1.0× 49 0.6× 70 0.9× 28 588
M Hirst United States 5 204 1.2× 272 1.9× 50 0.6× 73 0.8× 53 0.7× 8 768
Masato Kitajima Japan 15 79 0.5× 261 1.8× 77 0.9× 122 1.4× 113 1.5× 20 607
Shawn D. Seidel United States 10 71 0.4× 213 1.5× 274 3.1× 73 0.8× 46 0.6× 16 620
Leonard J. Lerner Malaysia 15 567 3.4× 232 1.6× 71 0.8× 54 0.6× 148 1.9× 49 1.0k
Jennifer E. Foreman United States 16 65 0.4× 453 3.1× 97 1.1× 41 0.5× 79 1.0× 30 794
Bhanu Singh United States 6 27 0.2× 206 1.4× 64 0.7× 102 1.2× 85 1.1× 12 581
Appavu Chandrasekaran United States 15 119 0.7× 178 1.2× 44 0.5× 92 1.0× 82 1.1× 43 595
Hui Wen Ng United States 16 136 0.8× 289 2.0× 123 1.4× 29 0.3× 30 0.4× 23 652
E. Perel Canada 16 466 2.8× 184 1.3× 95 1.1× 36 0.4× 134 1.8× 20 829

Countries citing papers authored by Jill Merrill

Since Specialization
Citations

This map shows the geographic impact of Jill Merrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Merrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Merrill more than expected).

Fields of papers citing papers by Jill Merrill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Merrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Merrill. The network helps show where Jill Merrill may publish in the future.

Co-authorship network of co-authors of Jill Merrill

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Merrill. A scholar is included among the top collaborators of Jill Merrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Merrill. Jill Merrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gordon, John, Matthew Johnson, Emily N. Reinke, et al.. (2021). Measuring U.S. Federal Agency progress toward implementation of alternative methods in toxicity testing. 2 indexed citations
2.
Bonzo, Jessica A., Todd Bourcier, Ikram Elayan, et al.. (2020). An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). Regulatory Toxicology and Pharmacology. 114. 104662–104662. 112 indexed citations
3.
Choksi, Neepa, George DeGeorge, Jamin A. Willoughby, et al.. (2020). Validation of the OptiSafe™ eye irritation test. Cutaneous and Ocular Toxicology. 39(3). 180–192. 6 indexed citations
4.
Choksi, Neepa, James Truax, Joanna Matheson, et al.. (2018). United States regulatory requirements for skin and eye irritation testing. Cutaneous and Ocular Toxicology. 38(2). 141–155. 20 indexed citations
5.
Blazka, Mark E., John W. Harbell, Mitchell Klausner, et al.. (2003). 163 Evaluating the ocular irritation potential of 54 test articles using the epiocular™ human tissue construct model (OCL-200). Toxicology Letters. 144. s47–s47. 12 indexed citations
6.
Merrill, Jill, et al.. (1995). Polybrominated biphenyl induction of cytochrome P450 mixed function oxidase activity in primary rat and human hepatocytes. Toxicology. 99(3). 147–152. 22 indexed citations
7.
Weisman, Robert A., J.W. Brodack, M. J. Welch, et al.. (1991). The use of cultured liver cells from rats and humans to study the metabolism of the PET imaging agent (F-18)-fluoroestradiol. Journal of Labelled Compounds and Radiopharmaceuticals. 30. 2 indexed citations
8.
Weisman, Robert A., et al.. (1991). The use of cultured liver cells from rats and humans to study the metabolism of the pet imaging agent fluorine 18 labeled fluoroestradiol. Journal of Labelled Compounds and Radiopharmaceuticals. 30. 426. 1 indexed citations
9.
Simpson, Evan R., et al.. (1989). Regulation of Estrogen Biosynthesis by Human Adipose Cells*. Endocrine Reviews. 10(2). 136–148. 151 indexed citations
10.
Merrill, Jill, et al.. (1988). Role of glutathione in the toxicity of the sesquiterpene lactones hymenoxon and helenalin. Journal of Toxicology and Environmental Health. 23(2). 159–169. 9 indexed citations
11.
Mendelson, Carole R., et al.. (1987). Regulation of the synthesis of aromatase cytochrome P-450 in human adipose stromal and ovarian granulosa cells. Steroids. 50(1-3). 51–59. 5 indexed citations
13.
Merrill, Jill, et al.. (1986). Helenalin: Mechanism of Toxic Action. Advances in experimental medicine and biology. 197. 891–896. 3 indexed citations
14.
Merrill, Jill, et al.. (1985). Hymenoxon: biologic and toxic effects. Biochemical Pharmacology. 34(18). 3383–3386. 5 indexed citations
15.
Merrill, Jill, et al.. (1985). The in vitro metabolism of benzo[a]pyrene by polychlorinated and polybrominated biphenyl induced rat hepatic microsomal monooxygenases. Canadian Journal of Physiology and Pharmacology. 63(9). 1096–1100. 8 indexed citations
16.
Robertson, Larry W., Andrew Parkinson, Stelvio M. Bandiera, et al.. (1984). PCBs and PBBs: Biologic and toxic effects on C57BL/6J and DBA/2J inbred mice. Toxicology. 31(3-4). 191–206. 46 indexed citations
17.
Merrill, Jill & Tammy Μ. Bray. (1983). Effects of species, MFO inducers and conjugation agents on the in vitro covalent binding of 14C-3-methylindole metabolite in liver and lung tissues. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 75(2). 395–398. 10 indexed citations
18.
Merrill, Jill & Tammy Μ. Bray. (1983). The Effect of Dietary and Sulfur Compounds in Alleviating 3-Methylindole-Induced Pulmonary Toxicity in Goats. Journal of Nutrition. 113(9). 1725–1731. 14 indexed citations
19.
Merrill, Jill, Richard M. Lambrecht, & Alfred P. Wolf. (1978). Cyclotron isotopes and radiopharmaceuticals—XXIV. Titanium-45. The International Journal of Applied Radiation and Isotopes. 29(2). 115–116. 16 indexed citations
20.
Merrill, Jill, Richard M. Lambrecht, & Alfred P. Wolf. (1973). Cyclotron production of lead-203 for radiopharmaceutical applications. The International Journal of Applied Radiation and Isotopes. 24(12). 701–702. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026